MedTrace Logo

Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms

NCT07265817 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-12-05

No results posted yet for this study

Summary

The aim of the study is to see whether fecal microbiota transplantation is effective to decolonize multidrug-resistant organisms.

Conditions

  • Carbapenem-Resistant Enterobacteriaceae Colonization

Interventions

COMBINATION_PRODUCT

Fecal Microbial transplant Capsules

3 pills per day for 3 consecutive days with placebo comparatator

COMBINATION_PRODUCT

Placebo

The same amount and shape capsules

Sponsors & Collaborators

  • Kyungpook National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2026-09-01
Completion
2027-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07265817 on ClinicalTrials.gov